Dual-Frequency Ultrasound Assisted Thrombolysis in Interventional Therapy of Deep Vein Thrombosis
© 2023 Wiley‐VCH GmbH..
Deep vein thrombosis (DVT) is one of the main causes of disability and death worldwide. Currently, the treatment of DVT still needs a long time and faces a high risk of major bleeding. It is necessary to find a rapid and safe method for the therapy of DVT. Here, a dual-frequency ultrasound assisted thrombolysis (DF-UAT) is reported for the interventional treatment of DVT. A series of piezoelectric elements are placed in an interventional catheter to emit ultrasound waves with two independent frequencies in turn. The low-frequency ultrasound drives the drug-loaded droplets into the thrombus, while the high-frequency ultrasound causes the cavitation of the droplets in the thrombus. With the joint effect of the enhanced drug diffusion and the cavitation under the dual-frequency ultrasound, the thrombolytic efficacy can be improved. In a proof-of-concept experiment performed with living sheep, the recanalization of the iliac vein is realized in 15 min using the DF-UAT technology. Therefore, the DF-UAT can be one of the most promising methods in the interventional treatment of DVT.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Advanced healthcare materials - 13(2024), 9 vom: 28. Apr., Seite e2303358 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Pan, Yunfan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Dual‐frequency |
---|
Anmerkungen: |
Date Completed 08.04.2024 Date Revised 08.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/adhm.202303358 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365901229 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM365901229 | ||
003 | DE-627 | ||
005 | 20240408232156.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231227s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/adhm.202303358 |2 doi | |
028 | 5 | 2 | |a pubmed24n1369.xml |
035 | |a (DE-627)NLM365901229 | ||
035 | |a (NLM)38099426 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Pan, Yunfan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Dual-Frequency Ultrasound Assisted Thrombolysis in Interventional Therapy of Deep Vein Thrombosis |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.04.2024 | ||
500 | |a Date Revised 08.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 Wiley‐VCH GmbH. | ||
520 | |a Deep vein thrombosis (DVT) is one of the main causes of disability and death worldwide. Currently, the treatment of DVT still needs a long time and faces a high risk of major bleeding. It is necessary to find a rapid and safe method for the therapy of DVT. Here, a dual-frequency ultrasound assisted thrombolysis (DF-UAT) is reported for the interventional treatment of DVT. A series of piezoelectric elements are placed in an interventional catheter to emit ultrasound waves with two independent frequencies in turn. The low-frequency ultrasound drives the drug-loaded droplets into the thrombus, while the high-frequency ultrasound causes the cavitation of the droplets in the thrombus. With the joint effect of the enhanced drug diffusion and the cavitation under the dual-frequency ultrasound, the thrombolytic efficacy can be improved. In a proof-of-concept experiment performed with living sheep, the recanalization of the iliac vein is realized in 15 min using the DF-UAT technology. Therefore, the DF-UAT can be one of the most promising methods in the interventional treatment of DVT | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a dual‐frequency | |
650 | 4 | |a interventional therapy | |
650 | 4 | |a nanodroplet | |
650 | 4 | |a thrombolysis | |
650 | 4 | |a ultrasound | |
650 | 7 | |a Fibrinolytic Agents |2 NLM | |
700 | 1 | |a Li, Yongjian |e verfasserin |4 aut | |
700 | 1 | |a Chen, Yuexin |e verfasserin |4 aut | |
700 | 1 | |a Li, Jiang |e verfasserin |4 aut | |
700 | 1 | |a Chen, Haosheng |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Advanced healthcare materials |d 2012 |g 13(2024), 9 vom: 28. Apr., Seite e2303358 |w (DE-627)NLM218710070 |x 2192-2659 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2024 |g number:9 |g day:28 |g month:04 |g pages:e2303358 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/adhm.202303358 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2024 |e 9 |b 28 |c 04 |h e2303358 |